Cancer of the esophagus and gastric cardia: recent advances.
about
Combined chemotherapy plus endostar with sequential stereotactic radiotherapy as salvage treatment for recurrent esophageal cancer with severe dyspnea: A case report and review of the literature.Individualized, multimodal palliative treatment of inoperable esophageal cancer: clinical impact of photodynamic therapy resulting in prolonged survival.Survival after chemotherapy and/or radiotherapy versus self-expanding metal stent insertion in the setting of inoperable esophageal cancer: a case-control study.Human papillomavirus DNA and P16(INK4A) expression in concurrent esophageal and gastric cardia cancersComparison of global gene expression of gastric cardia and noncardia cancers from a high-risk population in chinaAcid inhibitory medication and risk of gastric and oesophageal cancerGastric carcinomas localized to the cardia.When saliva meets acid: chemical warfare at the oesophagogastric junction.Tumor necrosis factor-α gene 308G/A polymorphism is not associated with esophageal squamous cell carcinoma risk in Kazakh patientsThe molecular basis of transdifferentiation.Results of management of esophageal and GE junction malignancies in Nepalese contextPresent status and progress of neoadjuvant chemoradiotherapy for esophageal cancer.Gastric cardia adenocarcinoma pathway analysis.Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma.Characterization of Gastric Cardia Tumors: Differences in Helicobacter pylori Strains and Genetic Polymorphisms.Complications of stent placement in patients with esophageal cancer: A systematic review and network meta-analysis.Anxiety and depressive disorders among patients with esophageal cancer in Taiwan: a nationwide population-based study.Elevated expression patterns and tight correlation of the PLCE1 and NF-κB signaling in Kazakh patients with esophageal carcinoma.Esophagogastric junction adenocarcinoma: multivariate analyses of surgical morbi-mortality and adjuvant therapy.p16 gene silencing along with p53 single-nucleotide polymorphism and risk of esophageal cancer in Northeast India.The future of the esophagus cancer.
P2860
Q33778324-DB01F815-ABE0-4051-8A51-5C496EB6602FQ34158992-67A8E650-245D-442D-9D0E-A5901D2A78E6Q34159618-5F933E25-BFC1-47DE-96BF-59258E2A49D0Q34406542-0C3E816B-3042-4343-879B-640E3AA2882EQ34744703-E0F899F5-C16A-4D91-9BCC-132E6A844521Q35769164-D295B437-2BCB-4EF1-9AF1-1E6360CCA6ECQ35821499-23B29577-331C-4904-96E8-DB4E37B80819Q35980464-D1A67063-C3DC-4209-AF70-BB93A9DC0524Q36095253-3FC18260-671A-4578-BAF8-58702561F66CQ36275668-4BC4A3FC-EE60-47AD-AAA5-AAC260E7732EQ36753842-A2B7C2FE-539A-499F-B81C-B00328E25174Q38107463-430554AB-5926-44B7-9952-4D5AF3706E35Q38212242-A47B2094-CDD4-46A5-8967-26719AB2530DQ40203442-D884C89C-EA03-4794-B3BD-44F0F2C41199Q41296247-197DB186-B64C-4177-8C6E-80C030C8943AQ42368939-B4CCCDC5-834B-48C5-9523-EFFD7431028DQ43638031-0EB4A55C-2080-42F3-94A5-2CC4D2ACACE7Q44037227-2FC83150-52F4-4C4D-8604-9D956D7DC3F0Q45226340-B3FC315C-C8F2-4EDD-A44E-089FB6DC4943Q51026395-B2562215-CDC7-4EF6-A2EC-49D79A12C216Q51384128-E49A86DF-F75A-4AC8-AB4B-135F8D5C248A
P2860
Cancer of the esophagus and gastric cardia: recent advances.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cancer of the esophagus and gastric cardia: recent advances.
@ast
Cancer of the esophagus and gastric cardia: recent advances.
@en
type
label
Cancer of the esophagus and gastric cardia: recent advances.
@ast
Cancer of the esophagus and gastric cardia: recent advances.
@en
prefLabel
Cancer of the esophagus and gastric cardia: recent advances.
@ast
Cancer of the esophagus and gastric cardia: recent advances.
@en
P2093
P2860
P1476
Cancer of the esophagus and gastric cardia: recent advances.
@en
P2093
G J A Offerhaus
G J Peters
G N J Tytgat
H Bartelink
J J B van Lanschot
P2860
P356
10.1111/J.1442-2050.2004.00371.X
P577
2004-01-01T00:00:00Z